Association between anti-SSSCA1 antibodies and cancer in systemic sclerosis.
Rachel S WallworkChristopher A MecoliLivia Casciola-RosenPublished in: Rheumatology (Oxford, England) (2022)
These data suggest anti-SSSCA1 antibody status may be of utility as a cancer biomarker in SSc. Anti-SSSCA1-positive patients with SSc may be more likely to have severe Raynaud's and cardiac involvement.